1. Home
  2. Liraglutide
  Subject:

Liraglutide   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Diabetes mellitus type 2 Glucagon-like peptide-1 Cell surface receptor Blood sugar Insulin Hypoglycemia Glucagon-like peptide-1 receptor agonist Fasting Exenatide Sitagliptin Liraglutide Obesity Glucose Blood plasma Protein Gene Messenger RNA Agonist Growth factor Body mass index Insulin resistance Metabolism Diabetes mellitus Metformin Pharmacokinetics Clinical trial AstraZeneca Dipeptidyl peptidase-4 Saxagliptin Enzyme inhibitor
RELATED SUBJECTS:
The publications listed also have these subjects
Diabetes mellitus type 2  17 times
Glucagon-like peptide-1  11 times
Cell surface receptor  8 times
Blood sugar  7 times
Insulin  5 times
Hypoglycemia  5 times
Glucagon-like peptide-1 receptor agonist  5 times
Fasting  5 times
Sitagliptin  4 times
Placebo  4 times
Insulin glargine  4 times
Metformin  3 times
Clinical trial  3 times
Blood plasma  3 times
Agonist  3 times
Hippocampus  2 times
Hemoglobin  2 times
Glycated hemoglobin  2 times
Glucose  2 times
Estrogen receptor  2 times
Empagliflozin  2 times
Dipeptidyl peptidase-4  2 times
Central nervous system  2 times
Tyrosine hydroxylase  1 time
Tumor necrosis factor alpha  1 time
Titration  1 time
Syndrome  1 time
Switzerland  1 time
Swedish language  1 time
Subcutaneous injection  1 time
Statin  1 time
Signal-to-noise ratio  1 time
Rotenone  1 time
Retinopathy  1 time
Renal replacement therapy  1 time
PubMed  1 time
Protein  1 time
Polymerase chain reaction  1 time
Pioglitazone  1 time
Phosphorylation  1 time
Phenotype  1 time
Pharmacokinetics  1 time
Peptide  1 time
PH  1 time
Obesity  1 time
Nuclear receptor  1 time
Netherlands  1 time
Mitogen-activated protein kinase  1 time
Microglia  1 time
Memory  1 time
Medicaid  1 time
Mass spectrometry  1 time
Logistic regression  1 time
Limbic system  1 time
Lactic acidosis  1 time
Kidney failure  1 time
Ion  1 time
Insulin resistance  1 time
Infarction  1 time
Hyperglycemia  1 time
Histocompatibility  1 time
Growth factor  1 time
Gluconeogenesis  1 time
Glucagon  1 time
France  1 time
Extracellular signal–regulated kinases  1 time
Enzyme inhibitor  1 time
Endemism  1 time
Embase  1 time
Dopamine  1 time
Dog  1 time
Disease  1 time
Diarrhea  1 time
Dentate gyrus  1 time
Cytokine  1 time
Confocal microscopy  1 time
Classical mechanics  1 time
Chromatography  1 time
C-Jun N-terminal kinases  1 time
Body mass index  1 time
Blood lipids  1 time
Biological half-life  1 time
Bcl-2-associated X protein  1 time
Bcl-2  1 time
Atherosclerosis  1 time
Astrogliosis  1 time
Astrocyte  1 time
Aspirin  1 time
Antibody  1 time
Albinism  1 time
Acid  1 time
6  1 time

Publications tagged with this subject: 21

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. A Review of the Long-Term Efficacy, Tolerability, and Safety of Exenatide Once Weekly for Type 2 Diabetes

2. Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK

3. Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice

4. Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2 Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the EVIDENCE Study, a Prospective, 2-Year Follow-up, Observational, Post-Marketing St

5. Differential mobility spectrometry tandem mass spectrometry with multiple ion monitoring for the bioanalysis of liraglutide

6. Glycemic Control in a Real-Life Setting in Patients with Type 2 Diabetes Treated with IDegLira at a Single Swiss Center

7. Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population

8. Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom

9. The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg

10. Modeling the Long-Term Cost-Effectiveness of IDegLira in Patients with Type 2 Diabetes Who are Failing To Meet Glycemic Targets on Basal Insulin Alone in The Netherlands

11. Combined metformin-associated lactic acidosis and euglycemic ketoacidosis

12. Interpreting Cardiovascular Endpoints in Trials of Antihyperglycemic Drugs

13. Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide

14. Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report

15. Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden

16. The Role of the Pharmacist in Managing Type 2 Diabetes with Glucagon-Like Peptide-1 Receptor Agonists as Add-On Therapy

17. Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom

18. Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson’s disease

19. Beneficial effects of liraglutide (GLP1 analog) in the hippocampal inflammation

20. Type 2 diabetes and cardiovascular prevention: the dogmas disputed

21. Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials


Questions?

Drop us a message.